Korean J Ophthalmol.  2013 Apr;27(2):130-132. 10.3341/kjo.2013.27.2.130.

A Case of CMV Endotheliitis Treated with Intravitreal Ganciclovir Injection

Affiliations
  • 1Dapartment of Ophthalmology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea. schinn@hanmail.net
  • 2Dapartment of Laboratory Medicine, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.

Abstract

We report a case of CMV corneal endotheliitis that was treated with intravitreal ganciclovir injection. A 56-year-old man who has suffered from uveitis was referred to our clinic due to corneal endothelial abnormality. Slit lamp examination showed a localized sectoral corneal edema and linear keratic precipitates along the boundary of edema. In spite of treatment with oral steroid and acyclovir, the disease progressed and two new coin-like lesions were developed. After topical ganciclovir and intavitreal injection of ganciclovir, the corneal lesions disappeared.

Keyword

CMV endotheliitis; Intravitreal ganciclovir injection

MeSH Terms

Antiviral Agents/administration & dosage
Cytomegalovirus Infections/*complications/*drug therapy
Endothelium, Corneal/*virology
Ganciclovir/*administration & dosage
Humans
Intravitreal Injections
Keratitis/*drug therapy/*virology
Male
Middle Aged
Antiviral Agents
Ganciclovir

Figure

  • Fig. 1 Slit lamp examination showed sectorial corneal edema, keratic precipitates along the boundary of edema.

  • Fig. 2 Two new coin-like lesions pointed by arrows developed 1 week after adding oral steroids to the treatment course.

  • Fig. 3 After ganciclovir 2 mg/0.05 mL was injected into the intra-vitreous space, corneal edema almost subsided and linear keratic precipitates disappeared. The cornea returned to a normal state.

  • Fig. 4 Specular microscopy shows the reduced number of endothelial cells after treatment of linear endotheliitis.


Cited by  2 articles

Clinical Manifestations and Outcomes of Treatment in Cytomegalovirus Endotheliitis
Young-Jun Kim, Woong-Sun Yoo, Yong-Seop Han, Inyoung Chung, Seong-Wook Seo, Ji-Myong Yoo, Jong-Moon Park, Min-Chul Cho, Seong-Jae Kim
J Korean Ophthalmol Soc. 2016;57(6):863-875.    doi: 10.3341/jkos.2016.57.6.863.

A Case of Cytomegalovirus Corneal Endotheliitis Almost Misdiagnosed as Corneal Graft Rejection
Rae Young Kim, Sung A Lim, Man Soo Kim
J Korean Ophthalmol Soc. 2016;57(6):994-998.    doi: 10.3341/jkos.2016.57.6.994.


Reference

1. Suzuki T, Ohashi Y. Corneal endotheliitis. Semin Ophthalmol. 2008. 23:235–240.
2. Krachmer JH, Mannis MJ, Holland EJ. Cornea. 2011. 3rd ed. St. Louis: Mosby;961–971.
3. Ohashi Y, Yamamoto S, Nishida K, et al. Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. Am J Ophthalmol. 1991. 112:419–423.
4. Koizumi N, Yamasaki K, Kawasaki S, et al. Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. Am J Ophthalmol. 2006. 141:564–565.
5. Koizumi N, Suzuki T, Uno T, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008. 115:292–297.e3.
6. Chee SP, Bacsal K, Jap A, et al. Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology. 2007. 114:798–803.
7. Fellay J, Venetz JP, Aubert JD, et al. Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir. Transplant Proc. 2005. 37:949–951.
8. Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events. Paediatr Drugs. 2009. 11:309–321.
9. Yutthitham K, Ruamviboonsuk P. The high-dose, alternate-week intravitreal ganciclovir injections for cytomegalovirus retinitis in acquired immune deficiency syndrome patients on highly active antiretroviral therapy. J Med Assoc Thai. 2005. 88:Suppl 9. S63–S68.
10. Kim JS, Joo MJ, Yoo JH. Histological changes of the retinal following high dose intravitreal ganciclovir injection in rabbit. J Korean Ophthalmol Soc. 1997. 38:1172–1178.
11. Ausayakhun S, Yuvaves P, Ngamtiphakom S, Prasitsilp J. Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir. J Med Assoc Thai. 2005. 88:Suppl 9. S15–S20.
12. Arevalo JF, Garcia RA, Mendoza AJ. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela. Eur J Ophthalmol. 2005. 15:610–618.
13. Heinemann MH. Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1989. 107:1767–1772.
14. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004. 24:676–698.
15. Choopong P, Tesavibul N, Rodanant N. Crystallization after intravitreal ganciclovir injection. Clin Ophthalmol. 2010. 4:709–711.
16. Eng KT, Lam WC, Parker JA, Yucel YH. Retinal toxicity of intravitreal ganciclovir in rabbit eyes following vitrectomy and insertion of silicone oil. Can J Ophthalmol. 2004. 39:499–505.
17. Saran BR, Maguire AM. Retinal toxicity of high dose intravitreal ganciclovir. Retina. 1994. 14:248–252.
18. Hwang YS, Shen CR, Chang SH, et al. The validity of clinical feature profiles for cytomegaloviral anterior segment infection. Graefes Arch Clin Exp Ophthalmol. 2011. 249:103–110.
19. Hwang YS, Lin KK, Lee JS, et al. Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Graefes Arch Clin Exp Ophthalmol. 2010. 248:263–269.
20. Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010. 94:1648–1652.
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr